2016
DOI: 10.3892/or.2016.4583
|View full text |Cite
|
Sign up to set email alerts
|

Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection

Abstract: Abnormal expression and promoter methylation of microRNAs (miRNAs) are common events during cervical carcinogenesis. Worldwide, infection by types 18 and 16 of human papillomaviruses (HPVs) is considered the major risk factor for cervical cancer development. It has been reported that expression of the miRNAs can be deregulated by specific HPV genotypes. In this study we analyzed the promoter methylation of 22 miRNAs and the expression of three miRNAs in 10 non-squamous intraepithelial lesions (Non-SIL) without… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
32
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(36 citation statements)
references
References 40 publications
(64 reference statements)
4
32
0
Order By: Relevance
“…In the present study, qRT-PCR analysis demonstrated that miR-124 was significantly downregulated in CC tissue samples and cancer cell lines. This finding was also verified by a study suggesting that abnormal promoter methylation and downregulation of miR-124 is a common event during cervical carcinogenesis (9).…”
Section: Discussionsupporting
confidence: 66%
See 1 more Smart Citation
“…In the present study, qRT-PCR analysis demonstrated that miR-124 was significantly downregulated in CC tissue samples and cancer cell lines. This finding was also verified by a study suggesting that abnormal promoter methylation and downregulation of miR-124 is a common event during cervical carcinogenesis (9).…”
Section: Discussionsupporting
confidence: 66%
“…miR-124 is one of the most studied and best characterized miRNAs with pivotal roles in several malignant processes, including tumor proliferation, motility and angiogenesis (7). It has been reported that miR-124 promoter is heavily methylated in CC cell lines, thus contributing to its slight expression in human CC specimens (8,9). miR-124 was discovered to be involved in MALAT1-miR-124-RBG2 axis where it affects growth and invasion of high-risk human papillomavirus-positive CC cells (10).…”
Section: Introductionmentioning
confidence: 99%
“…Emerging evidence shows that dysregulation of miRNAs plays a vital role in many biological processes, including proliferation, invasion and apoptosis (18). Hyper-methylation and reduced expression of anti-tumorigenic miRNAs’ promoters are associated with cancer progression in colorectal (19), chronic lymphocytic leukemia (20), cervical (21), breast (22), and gastric cancers (17,23). On the other hand, hypo-methylation of pro-oncogenic miRNAs’ promoters have been reported in hepatocellular carcinoma (24), pancreatic (25), and ERα positive breast cancers (26).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, DNA hypermethylation-associated repression of tumor suppressor genes has been reported to be essential for Ras-mediated transformation [26][27][28][29]. On the other hand, accumulating evidence shows that miRNA can be deregulated by epigenetic alterations such as aberrant DNA methylation in human cancer, including breast cancer [30][31][32][33][34][35][36][37][38][39]. Therefore, to test whether epigenetic alterations affect expression of miR-205, we treated cells with DNA methyltransferase (DNMT) inhibitor 5-aza-2 0 -deoxycytidine.…”
Section: Erbb2 Signaling Via Ras/raf/mek/erk Pathway Decreases Mir-20mentioning
confidence: 99%